United Kingdom News Beep | NewsBeep.com
  • News Beep
  • United Kingdom
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
United Kingdom News Beep | NewsBeep.com
United Kingdom News Beep | NewsBeep.com
  • News Beep
  • United Kingdom
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

The Company

21 posts
MMedication
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
Read More

FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval

  • August 7, 2026
NRx Pharmaceuticals, Inc. FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC,…
UUnited Kingdom
Hawke Electric Vehicles Expands Hire and Sales Operations to Full Nationwide Coverage Across the UK
Read More

Hawke Electric Vehicles Expands Hire and Sales Operations to Full Nationwide Coverage Across the UK

  • July 28, 2026
Hawke Electric Vehicles has expanded its electric vehicle hire and sales operations to full nationwide coverage, with vehicle…
UUnited Kingdom
Results of Fundraise and TVR
Read More

Results of Fundraise and TVR

  • July 8, 2026
Pulsar Helium THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR…
MMedication
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Read More

Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control

  • June 30, 2026
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
MMarkets
The Future of Finance? Google Is Bringing Betting Odds Directly To Your Screen, Sparking Calls For 'Addiction Warnings'
Read More

Cycurion, Inc. Completes Transformative Acquisition of Secuvant, LLC and Flagship Panoptic Cybersecurity Platform

  • June 23, 2026
MCLEAN, Va., June 09, 2026 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading…
UUnited Kingdom
Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
Read More

Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom

  • June 11, 2026
Rein Therapeutics 16 patients enrolled to date in trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) First patient…
EEnvironment
Ocean Power Technologies Expands International Defense Engagements Across Europe
Read More

Ocean Power Technologies Expands International Defense Engagements Across Europe

  • June 1, 2026
Ocean Power Technologies, Inc. MONROE TOWNSHIP, N.J., June 01, 2026 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE…
HHealthcare
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Read More

Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights

  • May 12, 2026
Tonix Pharmaceuticals Holding Corp. In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA®, 3,588 patients…
MMedication
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
Read More

Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression

  • April 3, 2026
In the Phase 3 study population (N=90) of patients with PPD, LPCN 1154 did not show a statistically…
MMedication
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
Read More

PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

  • April 1, 2026
– PGN-EDODM1 was generally well-tolerated with all adverse events mild or moderate and no serious adverse events reported…
HHealthcare
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Read More

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

  • March 16, 2026
Tonix Pharmaceuticals Holding Corp. TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia;…
UUnited Kingdom
DiagnosTear Advances UK Market Entry Through Commercial Collaboration with Hanson Medical
Read More

DiagnosTear Advances UK Market Entry Through Commercial Collaboration with Hanson Medical

  • February 20, 2026
Vancouver, British Columbia–(Newsfile Corp. – February 20, 2026) – DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) (“DiagnosTear” or…
United Kingdom News Beep | NewsBeep.com
www.newsbeep.com